Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Chlorpyrifos oxon activates glutamate and lysine for protein cross-linking

dc.contributor.authorMuñoz-Torrero López-Ibarra, Diego
dc.contributor.authorSchopfer, Lawrence M.
dc.contributor.authorLockridge, Oksana
dc.date.accessioned2023-02-22T11:55:29Z
dc.date.available2023-02-22T11:55:29Z
dc.date.issued2023
dc.date.updated2023-02-22T11:55:29Z
dc.description.abstractChronic low-dose exposure to organophosphorus (OP) toxicants is correlated with an increase in the risk of impaired cognition and neurodegenerative diseases. A mechanism to explain this relationship is needed. We suggest that the formation of organophosphate-induced high-molecular-weight protein aggregates that disrupt cell function may be the missing link. It has been demonstrated that such aggregation can be promoted by OP-labeled lysine. Alternatively, OP-labeled glutamate may be the initiator. To test this hypothesis, we treated MAP-rich tubulin Sus scrofa and human transglutaminase with chlorpyrifos oxon. Trypsin-digested proteins were subjected to liquid chromatography−tandem mass spectrometry followed by Protein Prospector searches to identify diethyl phosphate adducts and cross-linked peptides. We report the presence of diethyl phosphate adducts on the side chains of glutamate, lysine, and tyrosine, as well as cross-links between glutamate and lysine. Glutamate-lysine cross-linking could be initiated either by diethyl phosphate-activated glutamate or by diethyl phosphate-activated lysine to form stable isopeptide bonds between and within proteins. It was concluded that organophosphate-induced high-molecular-weight protein aggregates could promote brain dysfunction.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec728358
dc.identifier.issn0893-228X
dc.identifier.urihttps://hdl.handle.net/2445/193966
dc.language.isoeng
dc.publisherAmerican Chemical Society
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1021/acs.chemrestox.2c00333
dc.relation.ispartofChemical Research in Toxicology, 2023, vol. 36, num. 1, p. 112-121
dc.relation.urihttps://doi.org/10.1021/acs.chemrestox.2c00333
dc.rightscc by-nc-nd (c) Diego Muñoz-Torrero López-Ibarra, et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationMalalties neurodegeneratives
dc.subject.classificationPèptids
dc.subject.classificationProteïnes
dc.subject.classificationÀcids nucleics
dc.subject.otherNeurodegenerative Diseases
dc.subject.otherPeptides
dc.subject.otherProteins
dc.subject.otherNucleic acids
dc.titleChlorpyrifos oxon activates glutamate and lysine for protein cross-linking
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
728358.pdf
Mida:
4.13 MB
Format:
Adobe Portable Document Format